List of Tables
Table 1. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Monoclonal Antibodies for Alzheimer Disease Market Competitive Situation by Manufacturers in 2025
Table 4. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Monoclonal Antibodies for Alzheimer Disease Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Monoclonal Antibodies for Alzheimer Disease Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Monoclonal Antibodies for Alzheimer Disease, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Product Types and Applications
Table 12. Global Key Manufacturers of Monoclonal Antibodies for Alzheimer Disease, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibodies for Alzheimer Disease Companies by Tier (Tier 1, Tier 2, Tier 3), based on Monoclonal Antibodies for Alzheimer Disease Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoclonal Antibodies for Alzheimer Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Monoclonal Antibodies for Alzheimer Disease Sales by Region (Units), 2021–2026
Table 18. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2021–2026)
Table 19. Global Monoclonal Antibodies for Alzheimer Disease Sales by Region (Units), 2027–2032
Table 20. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2027–2032)
Table 21. Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region (US$ Million), 2021–2026
Table 22. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2021–2026)
Table 23. Global Monoclonal Antibodies for Alzheimer Disease Revenue by Region (US$ Million), 2027–2032
Table 24. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2027–2032)
Table 25. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2021–2026
Table 27. North America Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2027–2032
Table 28. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2021–2026
Table 29. North America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2021–2026
Table 32. Europe Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2027–2032
Table 33. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2021–2026
Table 42. Latin America Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2027–2032
Table 43. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue by Country (US$ Million), 2027–2032
Table 50. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Type (2021–2026)
Table 51. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Type (2027–2032)
Table 52. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Type (2021–2026)
Table 53. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Type (2027–2032)
Table 54. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Type (2021–2026)
Table 57. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Type (2027–2032)
Table 58. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2021–2026)
Table 59. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2027–2032)
Table 60. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Application (2021–2026)
Table 61. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units) by Application (2027–2032)
Table 62. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Application (2021–2026)
Table 63. Global Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Application (2027–2032)
Table 64. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Monoclonal Antibodies for Alzheimer Disease Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Application (2021–2026)
Table 67. Global Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Application (2027–2032)
Table 68. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2021–2026)
Table 69. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2027–2032)
Table 70. Biogen Company Information
Table 71. Biogen Description and Business Overview
Table 72. Biogen Monoclonal Antibodies for Alzheimer Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Biogen Monoclonal Antibodies for Alzheimer Disease Product
Table 74. Biogen Recent Developments/Updates
Table 75. Eli Lilly & Co. Company Information
Table 76. Eli Lilly & Co. Description and Business Overview
Table 77. Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly & Co. Monoclonal Antibodies for Alzheimer Disease Product
Table 79. Eli Lilly & Co. Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Monoclonal Antibodies for Alzheimer Disease Distributors List
Table 83. Monoclonal Antibodies for Alzheimer Disease Customers List
Table 84. Monoclonal Antibodies for Alzheimer Disease Market Trends
Table 85. Monoclonal Antibodies for Alzheimer Disease Market Drivers
Table 86. Monoclonal Antibodies for Alzheimer Disease Market Challenges
Table 87. Monoclonal Antibodies for Alzheimer Disease Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Monoclonal Antibodies for Alzheimer Disease
Figure 2. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Monoclonal Antibodies for Alzheimer Disease Market Share by Type: 2025 & 2032
Figure 4. 350mg/20mL Product Picture
Figure 5. 500mg/5mL Product Picture
Figure 6. Global Monoclonal Antibodies for Alzheimer Disease Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Monoclonal Antibodies for Alzheimer Disease Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Monoclonal Antibodies for Alzheimer Disease Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Monoclonal Antibodies for Alzheimer Disease Market Size (US$ Million), 2021–2032
Figure 13. Global Monoclonal Antibodies for Alzheimer Disease Sales (Units), 2021–2032
Figure 14. Global Monoclonal Antibodies for Alzheimer Disease Average Price (US$/Unit), 2021–2032
Figure 15. Monoclonal Antibodies for Alzheimer Disease Report Years Considered
Figure 16. Monoclonal Antibodies for Alzheimer Disease Sales Share by Manufacturers in 2025
Figure 17. Global Monoclonal Antibodies for Alzheimer Disease Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Monoclonal Antibodies for Alzheimer Disease Players: Market Share by Revenue in Monoclonal Antibodies for Alzheimer Disease in 2025
Figure 19. Monoclonal Antibodies for Alzheimer Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Monoclonal Antibodies for Alzheimer Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2021–2032)
Figure 22. North America Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2021–2032)
Figure 23. United States Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2021–2032)
Figure 26. Europe Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2021–2032)
Figure 27. Germany Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Region (2021–2032)
Figure 34. China Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2021–2032)
Figure 42. Latin America Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Monoclonal Antibodies for Alzheimer Disease Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Monoclonal Antibodies for Alzheimer Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Monoclonal Antibodies for Alzheimer Disease by Type (2021–2032)
Figure 53. Global Revenue Market Share of Monoclonal Antibodies for Alzheimer Disease by Type (2021–2032)
Figure 54. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Monoclonal Antibodies for Alzheimer Disease by Application (2021–2032)
Figure 56. Global Revenue Market Share of Monoclonal Antibodies for Alzheimer Disease by Application (2021–2032)
Figure 57. Global Monoclonal Antibodies for Alzheimer Disease Price (US$/Unit) by Application (2021–2032)
Figure 58. Monoclonal Antibodies for Alzheimer Disease Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
